Büller HR - Search Results

1

The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.

van Es N, Ventresca M, Di Nisio M, Zhou Q, Noble S, Crowther M, Briel M, Garcia D, Lyman GH, Macbeth F, Griffiths G, Iorio A, Mbuagbaw L, Neumann I, Brozek J, Guyatt G, Streiff MB, Baldeh T, Florez ID, Gurunlu Alma O, Agnelli G, Ageno W, Marcucci M, Bozas G, Zulian G, Maraveyas A, Lebeau B, Lecumberri R, Sideras K, Loprinzi C, McBane R, Pelzer U, Riess H, Solh Z, Perry J, Kahale LA, Bossuyt PM, Klerk C, Büller HR, Akl EA, Schünemann HJ; IPDMA Heparin Use in Cancer Patients Research Group. van Es N, et al. Among authors: buller hr. J Thromb Haemost. 2020 Aug;18(8):1940-1951. doi: 10.1111/jth.14824. Epub 2020 Jul 8. J Thromb Haemost. 2020. PMID: 32336010 Free article.

2

Treatment of symptomatic venous thromboembolism: improving outcomes.

Büller HR. Büller HR. Semin Thromb Hemost. 2002 Jun;28 Suppl 2:41-8. doi: 10.1055/s-2002-32315. Semin Thromb Hemost. 2002. PMID: 12073179 Review.

3

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, Büller HR. Strebel N, et al. Among authors: buller hr. Arch Intern Med. 2002 Jul 8;162(13):1451-6. doi: 10.1001/archinte.162.13.1451. Arch Intern Med. 2002. PMID: 12090880 Review.

4

Travel and the risk of symptomatic venous thromboembolism.

ten Wolde M, Kraaijenhagen RA, Schiereck J, Hagen PJ, Mathijssen JJ, Mac Gillavry MR, Koopman MM, Büller HR. ten Wolde M, et al. Among authors: buller hr. Thromb Haemost. 2003 Mar;89(3):499-505. Thromb Haemost. 2003. PMID: 12624634

5

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.

van Dongen CJ, Vink R, Hutten BA, Büller HR, Prins MH. van Dongen CJ, et al. Among authors: buller hr. Arch Intern Med. 2003 Jun 9;163(11):1285-93. doi: 10.1001/archinte.163.11.1285. Arch Intern Med. 2003. PMID: 12796064

6

Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis.

Locadia M, Sprangers MA, de Haes HC, Büller HR, Prins MH. Locadia M, et al. Among authors: buller hr. Thromb Haemost. 2003 Jul;90(1):101-7. Thromb Haemost. 2003. PMID: 12876632 Clinical Trial.

7

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.

Klerk CP, Smorenburg SM, Büller HR. Klerk CP, et al. Among authors: buller hr. Arch Intern Med. 2003 Sep 8;163(16):1913-21. doi: 10.1001/archinte.163.16.1913. Arch Intern Med. 2003. PMID: 12963564 Review.

8

Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.

Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV. Harenberg J, et al. Among authors: buller hr. Haematologica. 2003 Oct;88(10):1157-62. Haematologica. 2003. PMID: 14555312 Clinical Trial.

9

Antithrombotic therapy and cancer.

Di Nisio M, Squizzato A, Klerk CP, Richel DJ, Büller HR. Di Nisio M, et al. Among authors: buller hr. Curr Opin Hematol. 2004 May;11(3):187-91. doi: 10.1097/01.moh.0000130317.18163.83. Curr Opin Hematol. 2004. PMID: 15257019 Review.

10

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Büller HR, et al. Chest. 2004 Sep;126(3 Suppl):401S-428S. doi: 10.1378/chest.126.3_suppl.401S. Chest. 2004. PMID: 15383479 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

732 results

Search Page